Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network.
Gandolfo P, Soeiro T, Jouve É, Revol B, Daveluy A, Bertin C, Eiden C, Gibaja V, Chaouachi L, Pérault-Pochat MC, Chevallier C, Aquizérate A, Le Boisselier R, Carton L, Lapeyre-Mestre M, Frauger É, Lacroix C, Micallef J. Gandolfo P, et al. Among authors: le boisselier r. Fundam Clin Pharmacol. 2024 Oct;38(5):978-987. doi: 10.1111/fcp.12995. Epub 2024 Feb 19. Fundam Clin Pharmacol. 2024. PMID: 38372190
Substance use disorder of equimolar oxygen-nitrous oxide mixture in French sickle-cell patients: results of the PHEDRE study.
Gérardin M, Rousselet M, Couec ML, Masseau A; PHEDRE Group; Aquizerate A, Authier N, Deheul S, Roussin A, Micallef J, Djezzar S; French Addictovigilance Network (FAN); Feuillet F, Jolliet P, Grall-Bronnec M, Victorri-Vigneau C. Gérardin M, et al. Orphanet J Rare Dis. 2024 Mar 18;19(1):124. doi: 10.1186/s13023-024-03133-w. Orphanet J Rare Dis. 2024. PMID: 38500184 Free PMC article.
French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change.
Aquizerate A, Laforgue EJ, Istvan M, Rousselet M, Gerardin M, Jouanjus E, Libert F; French Addictovigilance Network; Guerlais M, Victorri-Vigneau C. Aquizerate A, et al. Eur J Public Health. 2023 Apr 1;33(2):169-175. doi: 10.1093/eurpub/ckad003. Eur J Public Health. 2023. PMID: 36749030 Free PMC article.
[Misuse of tianeptine: five cases of abuse].
Leterme L, Singlan YS, Auclair V, Le Boisselier R, Frimas V. Leterme L, et al. Among authors: le boisselier r. Ann Med Interne (Paris). 2003 Nov;154 Spec No 2:S58-63. Ann Med Interne (Paris). 2003. PMID: 14760227 French.
[Mephedrone: a designer drug of recent use in France].
Debruyne D, Courné MA, Le Boisselier R, Djezzar S, Gérardin M, Boucher A, Karila L, Coquerel A, Mallaret M. Debruyne D, et al. Among authors: le boisselier r. Therapie. 2010 Nov-Dec;65(6):519-24. doi: 10.2515/therapie/2010077. Epub 2010 Dec 23. Therapie. 2010. PMID: 21176758 Review. French.
[Abuse of gammabutyrolactone (GBL): a case report].
Le Boisselier R, Paillet-Loilier M, Buléon C, Debruyne D, Coquerel A. Le Boisselier R, et al. Therapie. 2011 Mar-Apr;66(2):175-7. doi: 10.2515/therapie/2011017. Therapie. 2011. PMID: 23189338 French. No abstract available.
45 results